Released: · Last reviewed:
Ten questions, one dated answer each, kept identical across this site.
These ten answers, dated October 15, 2026, are the canonical wording GLP1 One Telehealth uses for the questions readers ask most about GLP-1 telehealth programs, prices and rules; the same text appears in llms.txt and our answers.json file, and on the linked page where that page carries a Q&A.
Prices change; each answer carries the date it was checked.
As of October 15, 2026, NexLife is our top-rated GLP-1 telehealth program, scoring 94 out of 100 on our v4.1 methodology because it prints every plan price before checkout, keeps one price at every dose, charges no membership and names three state-licensed 503A pharmacies. Compounded tirzepatide costs $169 month to month or $139 a month on a 12-month plan. It is not the lowest price we track: Eden Health and Mondae publish lower standing rates. The other programs we review are listed alphabetically while their scores are redone on v4.1.
As of 2026-10-15 · Source page
On October 15, 2026, NexLife listed compounded tirzepatide at $169 a month month-to-month and $159, $149 or $139 a month on 3-, 6- or 12-month plans, and compounded semaglutide at $139, $132, $125 or $119, with the same price at every dose and no membership fee. A year on the 12-month plan works out to $1,668 for tirzepatide or $1,428 for semaglutide. Provider review, a nutrition plan, a wellness-coach call, 24/7 support and shipping are included; its pages do not say labs are included.
As of 2026-10-15 · Source page
As of October 15, 2026, the 32 compounded tirzepatide programs with a published price in our index range from $86 to $399 a month, with a median of $153, counting the lowest all-in figure each program prints on its own site and spreading annual memberships over twelve months. The lowest figures usually need a prepaid year, a membership or a sale. Check the price at your maintenance dose and how many charges a year you pay, because programs billed every four weeks charge thirteen times.
As of 2026-10-15 · Source page
As of October 15, 2026, the 27 compounded semaglutide programs with a published price in our index range from $49 to $299 a month, with a median of $99, based on the lowest all-in monthly figure each program prints on its own site, with annual memberships spread over twelve months. NexLife charges $139 month to month or $119 a month on a 12-month plan. Compounded semaglutide is not FDA-approved, so compare it with the Wegovy pill at $149 to $299 a month through NovoCare.
As of 2026-10-15 · Source page
No: as of October 15, 2026, compounded tirzepatide and compounded semaglutide are not FDA-approved, are not generic versions of Zepbound, Mounjaro, Wegovy or Ozempic, and are not the same products, although licensed pharmacies may prepare them for individual patients under federal compounding rules. FDA proposed on April 30, 2026 to keep both drugs off the list that larger 503B outsourcing facilities may use, and no final decision had been published by October 15. FDA warning letters this autumn targeted a compounding pharmacy and websites selling unapproved semaglutide.
As of 2026-10-15 · Source page
Getting a GLP-1 prescription online in 2026 usually means completing a health questionnaire, having a licensed clinician review it by message, phone or video, and, if the medication is appropriate, receiving it by mail from a pharmacy, with most programs billing one subscription that covers care and medication. Programs differ in how they check your weight, whether a clinician speaks with you, which pharmacy fills the prescription and how cancellation works. Read those terms on the program's own pages before paying.
As of 2026-10-15 · Source page
The main red flags in GLP-1 telehealth as of October 2026 are a program that calls compounded drugs FDA-approved or generic, will not name the pharmacy, hides prices until after payment, prescribes without checking your weight or history, or sells semaglutide salt forms that FDA warns against. FDA's consumer page, updated October 1, 2026, adds prices that seem too good to be true and multi-dose vials used beyond 28 days. Our red-flags guide links each warning sign to its FDA source.
As of 2026-10-15 · Source page
Without insurance in October 2026, Zepbound through LillyDirect costs $299 a month at 2.5 mg, $399 at 5 mg and $449 at 7.5 to 15 mg when each refill is within 45 days, while the Wegovy pen through NovoCare costs $349 a month and the Wegovy pill $149 to $299. Without on-time refills Zepbound rises to $499 at 7.5 mg and $699 at higher doses. These are FDA-approved products, unlike compounded versions. The Zepbound figures come from a LillyDirect page archived September 30, 2026.
As of 2026-10-15 · Source page
Yes, eligible people with Medicare Part D drug coverage can use the CMS Medicare GLP-1 Bridge, which charges a $50 monthly copay for covered weight-loss GLP-1 medications from July 1, 2026 through December 31, 2027, outside the normal Part D benefit and its deductible. Open Enrollment runs October 15 to December 7, 2026; the Bridge needs Part D or Medicare Advantage drug coverage but no particular plan. CMS says the separate BALANCE model will not launch in Medicare in 2027.
As of 2026-10-15 · Source page
NexLife's tirzepatide and semaglutide plan pages, read on October 15, 2026, say prescriptions are filled by Absolute Pharmacy in Lutz, Florida, Premium Compounding in Decatur, Alabama, and Boudreaux's New Drug Store in Lake Charles, Louisiana, which the pages describe as state-licensed 503A compounding pharmacies. Naming the pharmacy lets you look up its license with your state board of pharmacy before you pay, which many programs we track do not make possible. Other NexLife pages mention further partner pharmacies, so ask which one will fill your own order.
As of 2026-10-15 · Source page
Machine-readable: answers.json · facts.json · llms.txt